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Protein robustness promotes evolutionary innovations on large
evolutionary time-scales
Abstract
Recent laboratory experiments suggest that a molecule's ability to evolve neutrally is important for its
ability to generate evolutionary innovations. In contrast to laboratory experiments, life unfolds on
time-scales of billions of years. Here, we ask whether a molecule's ability to evolve neutrally-a measure
of its robustness-facilitates evolutionary innovation also on these large time-scales. To this end, we use
protein designability, the number of sequences that can adopt a given protein structure, as an estimate of
the structure's ability to evolve neutrally. Based on two complementary measures of functional
diversity-catalytic diversity and molecular functional diversity in gene ontology-we show that more
robust proteins have a greater capacity to produce functional innovations. Significant associations
among structural designability, folding rate and intrinsic disorder also exist, underlining the complex
relationship of the structural factors that affect protein evolution.
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Abstract 
Recent laboratory experiments suggest that a molecule’s ability to evolve neutrally is 
important for its ability to generate evolutionary innovations. In contrast to laboratory 
experiments, life unfolds on time scales of billions of years. Here, we ask whether a 
molecule’s ability to evolve neutrally – a measure of its robustness – facilitates 
evolutionary innovation also on these large time scales. To this end, we use protein 
designability, the number of sequences that can adopt a given protein structure, as an 
estimate of the structure’s ability to evolve neutrally. Based on two complementary 
measures of functional diversity – catalytic diversity and molecular function diversity in 
gene ontology – we show that more robust proteins have a greater capacity to produce 
functional innovations. Significant associations among structural designability, folding 
rate, and intrinsic disorder also exist, underlining the complex relationship of the 
structural factors that affect protein evolution. 
 
 
Introduction 
 
What makes a biological system able to produce evolutionary innovations {Müller, 
1991 #25}, new adaptations that may aid in survival and reproduction? Do some 
systems have a greater ability to innovate than others? A rigorous answer to these 
questions requires a systematic comparison of many different systems and the 
innovations they have produced. Whole organisms are not readily amenable to such 
systematic comparison. In contrast, molecular innovations can be more easily studied. 
This is because we know millions of protein sequences, as well as thousands of 
secondary and tertiary structures, and their associated functions. For this reason, we 
here address the opening questions with protein molecules and their functional 
diversity, which is a record of past evolutionary innovations.  
 Recent experimental work suggests that a molecule’s ability to evolve neutrally 
is important for its ability to evolve new functions. Such neutral evolution leaves a 
primary function of the molecule unchanged, while paving the way for new functions to 
emerge. Cases in point are the enzymes serum paraoxonase and cytochrome P450. 
These enzymes have a primary catalytic function, but they can also metabolize other, 
secondary substrates at greatly reduced rates {Bloom, 2007 #2479; Amitai, 2007 
#2480}. Laboratory evolution experiments show that neutral mutations which do not 
change the primary function of these enzymes can cause substantial fluctuations in their 
secondary activities. Natural selection can then rapidly increase these “promiscuous” 
activities {Aharoni, 2005 #26}. A different kind of experiment with two catalytic RNA 
molecules makes a similar point. In this experiment {Schultes, 2000 #27} mutagenized 
two ribozymes unrelated in sequence, structure, and catalytic activity. The authors 
created a path of single mutations through sequence space that connected the two 
ribozymes. After most of the steps in this path, the catalytic activity of the mutated 
molecules did not change much, except for a small transition region about halfway 
between the two starting molecules. In this region, the activity of one molecule switched 
to the activity of the other molecule. Here again, neutral mutations paved the way for a 
molecule with a new function. In both cases, the ability to evolve neutrally facilitated a 
molecule’s ability to acquire functional innovations. 
If these observations hold more generally, the following prediction arises for two 
different molecules A and B: If A can undergo more neutral mutations than B – it has 
greater mutational robustness than B – then A should also show a greater propensity to 
evolve new functions. This prediction has been confirmed for cytochrome P450 in 
another recent experiment {Bloom, 2006 #28}, which showed that thermostable or 
mutationally robust variants of this enzyme more readily evolve new catalytic activities.  
Theoretical work on RNA structures provides a larger context and intuitive explanation 
for this observation {Wagner, 2007 #29}. Populations of mutationally robust structures 
can explore a set of all possible genotypes rapidly through neutral mutations. They are 
thus genotypically diverse and can produce large amounts of structural variation by 
single point mutations. This increased access to structural diversity promotes 
evolutionary innovations, even though only a small fraction of structural variants may 
lead to new functions. 
 Laboratory experiments can explore evolutionary innovations on laboratory time 
scales. However, life unfolded on time scales of billions of years. Does the connection 
between robustness and evolutionary innovation hold on these vastly larger time scales? 
This is the question we address here. To do so, we need to analyze a protein structure’s 
ability to evolve neutrally – its mutational robustness – for many different structures. 
This ability is directly related to the number of sequences in a genotype space that can 
fold into a given structure, also known as the frequency or the designability of the 
structure. Because the sequences folding into a structure are typically connected in a 
large neutral network {Babajide, 1997 #95; Bastolla, 2003 #78}, a highly designable 
structure can tolerate many mutations.   
   We here show that more robust proteins show greater propensity for 
evolutionary innovation of new functions on vast evolutionary time scales. To this end, 
we use quantitative estimates of protein designability that can be determined from a 
protein’s contact density matrix {England, 2003 #82}, or from the diversity of 
sequences adopting a protein structure {Shakhnovich, 2005 #90}. As a record of past 
evolutionary innovations, we use the functional diversity of protein domains, as 
encapsulated in their diversity of enzymatic functions {Pegg, 2006 #30}, and in their 
gene ontology annotations {Ashburner, 2000 #42} of molecular functions.  
 
Methods  
 
Our source of protein structures is the CATH (Class, Architecture, Topology, 
Homologous superfamily) database version 3.1.0 {Greene, 2007 #1}, and the 1,924 
representative domains in CATH that exceed a minimal length of 50 residues. The 
number of different functions known for a domain depends on the time since a domain 
originated in evolution: For two domains – one young, one old – with equal 
designability (robustness), the young domain had less time to accumulate sequence and 
functional diversity. We exclude this confounding factor by focusing some of our 
analyses on a subset of  ancient domains that are present in all sequenced bacterial, 
archaeal, and eukaryotic genomes {Ranea, 2006 #4}, and that were thus present in the 
last universal common ancestor of extant life. Since this dataset was derived from a 
previous CATH release, we filter these domains to obtain 112 ancient domains that 
occur in the current release.   
 In our analysis, we use two complementary estimates of a protein fold’s 
designability. We refer to these estimates as structural designability (DS) and diversity 
designability (DD). Structural designability was introduced by England and 
Shakhnovich {England, 2003 #7; Shakhnovich, 2005 #8}. These authors showed that 
the number of sequences that can adopt a given structure is approximated by the length-
normalized maximum eigenvalue of the contact density matrix at a defined distance 
cutoff, based on a coarse grained structural description (using only Cα and Cβ atoms). 
The contact density matrix A=(aij) is a binary (0-1) matrix, where aij=1 if two residues i 
and j that are not neighbors (|i-j|>1) are in contact. For our purpose, we consider two 
non-neighboring residues in contact, if any of their Cα and Cβ atoms occur within a 6.0 
Å radius of each other.  An alternative measure of structural designability is the average 
number of atomic contacts per residue {Bloom, 2006 #11; England, 2003 #7}. 
However, this measure is so closely correlated with DS (Spearman’s s = 0.989; P<10-298) 
that it yields virtual identical results. We thus focus exclusively on the length-
normalized structural designability: DS. 
We obtain our second estimate of designability (DD) from diversity data of 
protein sequences, in an approach similar to that of {Shakhnovich, 2005 #8}. 
Specifically, we analyze sequences in the non-redundant data set NRDB90 {Holm, 
1998 #3}. We examine each sequence in this set, and assign it to an ancient 
representative CATH domain, if the sequence has 25% or more identity to the CATH 
representative. We use BLAST {Altschul, 1997 #6} to determine the extent of sequence 
identity. Since the number of similar sequences observed per representative domain is 
dependent on its length, we also normalize DD by sequence length. 
 Because designability may be related to the complexity and amount of disorder 
of a protein fold, we also explored their relationship with functional diversity. As a 
measure of fold complexity, we used the absolute contact order as introduced by Plaxco 
et al., (1998) {Plaxco, 1998 #10}. Absolute contact order is the average distance on the 
amino acid sequence of two residues that contact each other in the structure. Proteins 
with high absolute contact order fold slowly. We calculate absolute contact order as in  
{Ivankov, 2003 #22}, where we consider two residues to be in contact if any of their Cα 
or Cβ are inside a sphere of 6,0Å.  
To explore intrinsic disorder (ID) in the sequence domain dataset described 
above, we use the tool IUPred {Dosztányi, 2005 #16; Dosztányi, 2005 #15}. Briefly, 
IUPred estimates for each residue in a sequence an index that indicates the amount of 
disorder this residue is subject to. We calculate the disorder average for each sequence 
in the NRDB90 dataset and assign this value to CATH representative domains if a 
BLAST sequence comparison presents an identity percentage greater than 25%. 
 
Functional annotation 
We estimate the capacity to evolve functional innovations using information from two 
sources. The first is the SFLD (Structure-Function Linkage Database) database that 
associates sequence, structure, and functional annotation for a diverse spectrum of 
enzyme superfamilies. This functional annotation is based on structural similarities of 
enzyme active sites {Pegg, 2006 #30}. In September 2007, the SFLD database 
contained 6280 protein sequences grouped in 138 families and 6 superfamilies. We 
determined the diversity of functions on the family level for all sequences that shared 
more than 25% identity with any of the CATH representative domains. 
We express functional diversity of a domain in two ways. The first (FE1) is 
simply the number of different SFLD families assigned per domain,  and normalized by 
the domain length. The second (FE2) is a measure akin to an entropy that takes into 
account the frequency of different enzymatic functions observed per domain. If a set of 
sequences associated with a domain has k different associated enzymatic functions 
(some of which may occur multiple times), and if pi is the frequency with which each 
function i occurs in the set of sequences, then FE2= ∑
=
−
k
i
ii pp
1
log . 
 
The second source of functional information used in this study is the Gene Ontology 
Annotation database (GOA) which maps UniProt {The UniProt, 2007 #31} entries to 
GO terms {Camon, 2004 #11}. We obtained the GOA database from the EMBL-EBI ftp 
site (ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/UNIPROT), and filtered the complete 
database to obtain only those UniProt entries annotated with molecular functions. We 
then created a non redundant database of sequences using the NRDB90 tool {Holm, 
1998 #225}. Subsequently, we examined each sequence in this database with, and 
mapped the associated GO terms to a CATH representative domain, if the sequence 
shared more than 25% identity with the CATH domain. Analogous to enzymatic 
diversity, we express molecular function diversity in two ways. The first (FG1) is simply 
the number of different GO molecular functions per domain, normalized by domain 
length. The second is the entropy measure described above, but now for the frequency 
distribution of GO terms observed per representative domain (FG2).  
 
Statistics 
All statistical analyses were carried out with the statistics software R, version 2.1.1 (R 
Development Core Team 2005; http://www.r-project.org/). For Principal Component 
Regression (PCR) analysis we used the R package ‘pls’.  
 
 
 
Results 
 
More designable proteins show a greater capacity to produce enzymatic diversity. We 
here use two complementary measures of protein designability. The first of them is 
structure designability (DS), as estimated by the length-normalized principal eigenvalue 
of a protein’s contact density matrix {England, 2003 #82}. The contact density matrix 
A=(aij) is a binary (0-1) matrix, where aij=1 if two non-neighboring residues i and j (|i-
j|>1) are in contact. Its principal eigenvalue is an approximation to the number of 
amino-acid contacts per residue. The measure DS reflects the number of groups of 
interacting amino acids. A large number of such groups allows more sequences to adopt 
a structure by relaxing energy constraints for the rest of the sequence {Shakhnovich, 
2005 #90}.  
Our second measure is diversity designability (DD), which is the number of 
sequences from a non-redundant database (see Methods) that fold into a structure, 
normalized by the sequence length. This second measure is vulnerable to a confounding 
factor, the different age of proteins. Old proteins may have more sequences associated 
with them than younger proteins, just because they originated early in life’s evolution. 
To exclude this factor, we restricted our analysis of diversity designability (DD) to a set 
of 112 ancient protein domains in the CATH database that were likely present in the 
most recent common ancestor of all extant life {Ranea, 2006 #4}. Both measures of 
designability are highly correlated for this age-corrected set of domains (Spearman’s 
r=0.88; P<7.25x10-53; Table 1) and for the complete set of more than 1924 CATH 
domains (Spearman’s r=0.89; P<10-298; Figure 2a). Similar associations have been 
reported for different domain datasets {Shakhnovich, 2005 #90}. They suggest that DS 
is reflective of the number of sequences that adopt a structure.   
  
We used two complementary measures of protein functional diversity. The first 
is a measure of diversity of enzymatic functions, based on structural similarities of 
enzyme active sites. The relevant information is curated in a recently developed 
database, which classifies enzymes into three hierarchical levels of function, of which 
we use the lowest (familial) level here {Pegg, 2006 #30}. We use two quantitative 
indicators of enzymatic functional diversity. These are FE1, the number of enzyme 
families associated with a protein domain, and FE2, which takes into account that 
different enzymatic functions occur at different frequencies in a set of sequences 
associated with a domain (see Methods). We explored the association between protein 
designability and functional diversity for these two different notions of functional 
diversity.  
 
Figure 1a shows an example of two structures with very different designabilities 
(DD). The color spectrum in the tertiary structure ranges from blue to red, corresponding 
to positions with low and high sequence diversity (DD), respectively. The structure on 
the left has lower designability and lower functional diversity, as indicated by the 
number of associated enzymatic functions, than the structure on the right. The less 
designable domain is associated with 2 enzyme superfamilies and 3 families, whereas 
the more designable domain is associated with 4 enzyme superfamilies and 11 families. 
Figure 1b shows a scatterplot of DD and enzymatic functional diversity (FE1) for 8 
arbitrarily chosen ancient structures that are color-coded in the same way. It suggests 
that the difference evident from Figure 1a is not just a peculiarity of the two sequences 
chosen. 
 
For the complete dataset of ancient domains, we observe a statistically 
significant and highly positive association between enzymatic functional diversity and 
DD (Spearman’s r= 0.80; P<2.31x10-40; Figure 3a). A structure with more associated 
sequences might be expected to have more associated functions, but this association 
persists if we normalize the number of functions by the total number of sequences 
associated with each fold (Spearman’s r=0.44;P<1.95x10-15). We also examined the 
association between structural designability DS and enzymatic functional diversity. This 
association is also positive, regardless of whether we normalize for the number of 
sequences associated with a fold (Spearman’s r=0.55; P<1.24x10-20) or not (Spearman’s 
r=0.70; P<1.09x10-30; Figure 3b). An even higher positive association exists if we use 
the frequency-weighted measure of enzymatic functional diversity, FE2 (DD: 
Spearman’s r= 0.88; P<7.13x10-52; DS: Spearman’s r= 0.88; P<7.13x10-52).  
  
More designable proteins show greater overall diversity of molecular functions. Our 
second measure of functional diversity encompasses gene ontology annotations of 
molecular functions. The gene ontology (GO) database includes the most 
comprehensive information about functional diversity of proteins. It is not restricted to 
enzymes. The Gene Ontology project has developed a dynamic controlled vocabulary 
based on three aspect of function (molecular function, process and location) that 
encompass complementary notions of gene functions in living cells {Ashburner, 2000 
#42}. For our purpose, the appropriate aspect of function is molecular function. We 
used two measures of molecular function diversity. The first (FG1) is simply the number 
of molecular function annotations associated with a protein domain, the second (FG2) 
weights different functions by their frequency in a set of proteins (see Methods).   
  
We observe a statistically significant and highly positive association between 
functional diversity (FG1) and DD, regardless of whether we normalize for the number 
of sequences per domain (Spearman’s r= 0,62; P<1.53x10-24) or whether we do not 
normalize (Spearmann’s r=0,96; P<2.5x10-79; Figure 3c). We also examined the 
association between DS and FG1, which is positive independent of whether the values 
are normalized (Spearman’s r=0,86; P<1.94x10-48) or whether do not normalize (Figure 
3d; Spearman’s r= 0.94; P<2.99x10-68). An even higher positive association exists if we 
use the frequency-weighted measure of functional diversity, FG2  (DD: Spearman’s r= 
0,87; P<3.48x10-50; DS: Spearman’s r= 0.97; P<4.08x10-88). 
 
Fold complexity and intrinsic disorder influence designability and diversity. Protein 
designability may be correlated with a number of other protein properties. Although 
such properties are not the main focus of our analysis, we wanted to examine how some 
of them relate to functional diversity. The first of these properties is the complexity of a 
protein fold. Among various available measures {Arteca, 1995 #226; Enright, 2005 
#227}, we use the absolute contact order as a measure of fold complexity. Absolute 
contact order is the average distance on the amino acid sequence of two residues that 
contact each other in the structure. It can be thought of as a measure of how “entangled” 
a structure is. It is a good predictor of a protein’s folding rate, regardless of whether the 
folding kinetics is dominated by one or by several steps {Ivankov, 2003 #22}. Highly 
designable proteins have low fold complexity. (DS: Spearman’s r=-0,70; P<9.11x10-91; 
DD: Spearman’s r=-0,66; P<1.14x10-27) (Figure 2b).  
 Secondly, we also explore the relationship between designability and a measure 
for the amount of conformational disorder a protein can tolerate. Highly disordered 
proteins are more flexible than others. The measure we use is the “intrinsic disorder” of 
a protein, as defined in {Dosztányi, 2005 #16}.  Specifically, we here use the average 
intrinsic disorder of the set of sequences associated with each CATH representative 
domain (see Methods). We would predict that proteins with high intrinsic disorder can 
tolerate more sequence change, and that they might thus also be more designable. This 
is the case (DS: Spearman’s r= 0.92; P<10-298; DD: Spearman’s r= 0.90; P<4.07x10-56) 
(Figure 2c).  Not surprisingly, these properties are also associated with each other 
(Table 1).  
 Because protein fold complexity and disorder are associated with designability, 
they might also be associated with functional diversity. This is indeed the case (Table 
1). Diversity of enzymatic and general molecular functions increases for short proteins 
(FE1: Spearman’s r=-0.685; P<2.33x10-29; FG1: Spearman’s r=-0.94; P<1.22x10-68), for 
proteins with low fold complexity (FE1: Spearman’s r=-0.63;P<3.6x10-25; FG1: 
Spearman’s r=-0.77;P<2.22x10-36), and for proteins with high intrinsic disorder (FE1: 
Spearman’s r=0.71;P<6.22x10-31 ; FG1: Spearman’s r=0.93;P<1.1x10-65).  
The pairwise associations we have discussed so far may conceal subtle 
interactions among the multiple variables we consider here. To better disentangle their 
relationship, we thus performed a principal component regression analysis. This 
analysis allows us to understand how three critical variables – designability, fold 
complexity, disorder – contribute to functional diversity. The results of this analysis 
reveal no unforeseen new relationships (Figure 4). One dominant principal component 
accounts for more than 80% of the variance in functional diversity. This component is 
dominated by the positive role of designability and intrinsic disorder for functional 
diversity, and by the negative role of fold complexity (Figure 4). The second and third 
principal components contribute only 15 and 4 percent of the variance, respectively.  
Similar results (not shown) hold if diversity designability or enzyme functional diversity 
are used in the analysis.  
 
 
 
 
 
 
Discussion 
 
In sum, we showed that highly designable proteins show a greater capacity to evolve 
functional innovations. Our measure of functional diversity estimates a given domain’s 
ability to explore sequence space and access a diverse spectrum of functions. Because 
functional diversity is a record of past evolutionary innovations, this means that more 
designable proteins have a greater facility to evolve new functions. In addition, because 
proteins of similar structure are connected in genotype space {Babajide, 1997 #95; 
Babajide, 2001 #94; Bornberg-Bauer, 1997 #101; Bastolla, 1999 #79; Wroe, 2007 
#228}, this means that more robust proteins show greater propensity to evolve 
functional innovations. This association holds for two complementary measures of 
functional diversity, diversity of enzymatic functions, and gene-ontology based 
diversity of molecular functions. It also holds for two different measures of 
designability, one based purely on structural information, the other based on the number 
of sequences associated with each protein fold. The associations persist if we correct for 
the different numbers of sequences associated with a fold. For gene ontology 
annotations, these associations are also corroborated by an analysis based on a different 
domain data set {Shakhnovich, 2005 #90}, whose main focus was to explain different 
sequence family sizes associated with different folds.  
 A number of other protein properties are associated with designability, and thus, 
not surprisingly, with functional diversity. Specifically, long proteins, proteins with 
complex folds (and thus proteins with slower folding rates; {Ivankov, 2003 #22}), and 
proteins with low amounts of disorder in their tertiary structure show low functional 
diversity. Most of these associations have intuitive explanations. For example, it is easy 
to see how high complexity of a fold may lead to smaller numbers of sequences being 
able to adopt a fold.  
 With respect to disorder in protein structures, conflicting interpretations can be 
brought to bear on its relationship to designability. On one hand, a more disordered 
structure may be more flexible, and thus tolerate more amino acid changes, implying 
greater robustness and designability. On the other hand, a disordered structure may be 
less thermodynamically stable {Dosztányi, 2005 #16}, and greater thermodynamical 
stability has been associated with robustness {Bloom, 2006 #28; Bastolla, 2005 #19}. 
Although explanations that could resolve this conflict have been put forth {Bastolla, 
2005 #19}, such resolution is not within the scope of this contribution.  
 Complex relationships with other variables notwithstanding, it is clear that 
designable and robust proteins have evolved many novel functions. This shows that a 
pattern derived from recent experimental findings, and applicable only to laboratory 
time scales, also holds on vastly greater geological time scales {Bloom, 2006 #28; 
Aharoni, 2005 #26}. The likely explanation has its root in how populations explore vast 
sequence spaces: populations of highly robust folds can explore sequence space rapidly, 
and thus access large amounts of structural diversity in their neighborhood {Wagner, 
2007 #29}. A small fraction of this diversity can subsequently give rise to proteins with 
new functions.  
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Table 1 
 Spearman rank correlation coefficients.  
DS: structural designability; DD: diversity designability; FE1: enzymatic functional 
diversity; FG1: diversity of molecular functions (based on Gene Ontology); FE2: 
entropic measure of enzymatic functional diversity; FG2: entropic measure of molecular 
function diversity (GO); ACO: absolute contact order; ID: intrinsic disorder;. The 
upper-right triangle shows Spearman rank correlation coefficients (r). The lower-left 
triangle of this table shows the corresponding p-values. Diversity designability as well 
as functional diversity measures are reported for the set of highly conserved 
evolutionary domians. 
 
DS DD FE1 FG1 FE2 FG2 ACO ID 
DS - 0,882 0,702 0,938 0,877 0,973 -0,698 0,923
DD 7,25E-53 - 0,801 0,961 0,877 0,868 -0,662 0,897
FE1 1,09E-30 2,31E-40 - 0,818 0,872 0,700 -0,625 0,705
FG1 2,99E-68 2,50E-79 1,69E-42 - 0,916 0,938 -0,765 0,931
FE2 7,13E-52 7,13E-52 6,40E-51 5,42E-61 - 0,886 -0,604 0,889
FG2 4,08E-88 3,48E-50 1,58E-30 2,99E-68 1,09E-53 - -0,638 0,952
ACO 9,11E-91 1,14E-27 3,56E-25 2,22E-36 7,25E-24 5,07E-26 - -0,607
ID 1,28E-129 4,07E-56 6,23E-31 1,08E-65 2,50E-54 2,29E-74 1,00E-129 -  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1A. An example of protein domains with different designability and 
different functional diversity. The color spectrum indicates a measure of diversity 
designability, where blue (red) indicates regions and domains with low (high) sequence 
diversity per residue. The enzyme families associated with each domain are listed 
below. Left. A domain with low designability (CATH id: 1mw9X04: Topoisomerase 1, 
domain 4.). It has a complex fold and is associated with  3 enzyme families that fall into 
two superfamilies {Pegg, 2006 #30}. Right. A domain with high designability 
(1ls1A01: The A subunit of the Four Helix Bundle Hemerythrin domain). It has a 
simpler fold and is associated with 11 enzyme families and 4 superfamilies.  Families 
(Superfamilies) are listed below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1mw9X04: Topoisomerase 1, domain 4 
Amidohydrolase superfamily 
 1. Dihydroorotase 3   
  
 2. Triazine hydrolase  
  
 
Crotonase superfamily 
 1. 1,4-dihydroxy-2-napthoyl-CoA synthase  
      
 
1ls1A01: The A subunit of the Four Helix Bundle Hemerythrin domain 
Amidohydrolase superfamily 
1. Triazine hydrolase  
 
Crotonase superfamily 
 1. Enoyl-CoA hydratase  
  
 2. Methylglutaconyl-CoA hydratase 
  
 3. Methylmalonyl-CoA decarboxylase  
  
 4. 3-hydroxyisobutyryl-CoA hydrolase 
  
 
Enolase superfamily 
 1. Glucarate dehydratase 
  
 2. o-succinylbenzoate synthase 
  
 3. Enolase 
   
 4. Galactonate dehydratase 
  
Haloacid dehalogenase superfamily 
 1. Phosphoserine phosphatase 
    
2. P-type atpase 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1B 
Functional diversity (FE1) increases with  protein designability. The color spectrum 
indicates a measure of diversity designability DD, where blue (red) indicates regions and 
domains with minimum (maximum) sequence diversity estimated per residue. 
Functional diversity (FE1) is expressed as the number of different enzyme families per 
representative CATH domain {Pegg, 2006 #30}. Eight highly conserved CATH 
domains (1n55A00, 1qz5A01, 1q6zA03, 1rl6A02, 1k7wA03, 1ls1A01, 1vq8V00, 
2bm0A03) have been arbitrarily chosen to illustrate the association between functional 
diversity (FE1) and designability (DD).  
 
 
 
 
 
 
Figure 2. Designability, fold complexity, and disorder are associated properties. 
A. Diversity designability (DD) vs. structural designability (DS). B. Fold complexity 
(ACO) vs. structural designability (DS). C. Intrinsic disorder (ID) vs. structural 
designability (DS). DD corresponds to the total number of sequences per residue per 
representative domain. ID is calculated as a length-normalized average per 
representative domain. Decadic logarithm is applied. 
 
 
 
Figure 3: Functionally diverse proteins are highly designable. A. Enzymatic 
functional diversity (FE1) as a function of diversity designability (DD). B. Enzymatic 
functional diversity (FE1) as a function of structural designability (DS). C. Molecular 
(gene ontology) functional diversity (FG1) as a function of diversity designability (DD). 
D.  Molecular (enzymatic) functional diversity (FG1) as a function of structural 
designability (DS). Functional diversity measures shown are normalized by the total 
number of sequences associated with each representative domain. DD corresponds to the 
length-normalized number of sequences per representative domain.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Principal component regression analysis of molecular function diversity 
(gene ontology) against structural designability (DS), fold complexity (ACO), and 
intrinsic disorder (ID) of folds fold. Shown are the two principal components that 
together account for 96,6% of the variance observed for functional diversity. 
Component 1 (Comp1) and Component 2 (Comp2) accounts for 80,8% and 15,8% of 
the total variance, respectively.   
 
